Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acrivon Therapeutics, Inc.

2.09
+0.02000.97%
Volume:323.28K
Turnover:679.88K
Market Cap:65.74M
PE:-0.93
High:2.14
Open:2.12
Low:2.05
Close:2.07
52wk High:8.74
52wk Low:1.05
Shares:31.46M
Float Shares:16.70M
Volume Ratio:0.84
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2435
EPS(LYR):-2.3839
ROE:-47.87%
ROA:-30.32%
PB:0.46
PE(LYR):-0.88

Loading ...

Jul 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 11, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Correspondence

Form CORRESP - Correspondence